Website & contact details
- Website
Life Science Group Limited
- Incorporated
- 29 May 2008 (18 years)
- Previously known as
- Antibody Production Services Limited (until 12 July 2016)This list may be incomplete. See all names on Companies House
- Industry
- Manufacture of other chemical products n.e.c. (20590) Manufacture of basic pharmaceutical products (21100)Research and experimental development on biotechnology (72110)Other service activities n.e.c. (96090)
- Owned by
- Jennifer Ann Murray
- Accounts type
- Total exemption full
- Region
- East of England
- Address
- 137 Watling StreetRadlettWD7 7NQ
Filing status
- Accounts due
- 29 February 2028
- Last accounts
- 31 May 2026
- Conf. stmt due
- 15 October 2027
- Last conf. stmt
- 1 October 2026
Charges
- Total
- 3
- Outstanding
- 3
- Part satisfied
- 0
- Satisfied
- 0
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 1 September 2013
British
Born February 1945 (81)
Director · Appointed 29 May 2008
British
Born April 1960 (66)
Officer history (5 former)
4 October 2023
Resigned Littlewood, Andrew Michael as Director
1 July 2022
Appointed Littlewood, Andrew Michael as Director
4 December 2019
Resigned Brewer, Mark Neville as Director
20 February 2017
Appointed Brewer, Mark Neville as Director
24 March 2014
Resigned Sapsford, Kelly Karensa as Director
1 September 2013
31 January 2011
Resigned Ollif, Christopher Ronald as Secretary
29 May 2008
29 May 2008
Appointed Sdg Registrars Limited as Corporate Director
29 May 2008
Resigned Sdg Registrars Limited as Corporate Director
29 May 2008
Appointed Ollif, Christopher Ronald as Secretary
29 May 2008
Appointed Sapsford, Kelly Karensa as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Individual · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
British
Born April 1960 (66)
Financials
Figures from 2025 accounts. Newer accounts, made up to 31 May 2026, are filed but not read yet. See them on Companies House
Trend
Net Assets
No net assets figure read from accounts after 2024.
Balance sheet detail
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Fixed Assets | £2,624,455 | £2,602,807 | |
| Current Assets | £1,698,471 | £1,927,932 | |
| Debtors | £625,300 | £976,104 | |
| Cash | £153,289 | ||
| Creditors (< 1 year) | £935,730 | £2,104,601 | |
| Creditors (> 1 year) | £714,090 | ||
| Net Current Assets | £762,741 | (£176,669) | |
| Net Assets | £2,673,106 | £2,426,138 | |
| Shareholder Funds | £2,673,106 | £2,426,138 |
What Life Science Group say about themselves
“UK CDMO for cell culture media, buffers, sera and transport media, including FBS, human AB serum, hPL, T-Store and CellShip, plus custom manufacturing.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 26 August 2026 | Total exemption full accounts | 31 May 2026 | ||
| 9 February 2026 | Total exemption full accounts | 31 May 2025 | ||
| 5 December 2025 | Confirmation statement with updates | 3 December 2025 | ||
| 7 February 2025 | Registered office address changed | |||
| 8 January 2025 | Total exemption full accounts | 31 May 2024 |
Some other companies at this address
Other companies in this industry
Newton Abbot
Birmingham
Wickford
Peterborough
Glasgow
Nottingham
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →